When a business partner or co-shareholder dies, the business doesn’t pause. Decisions need making. Control needs clarity. And the buy-sell agreement, which may have sat in a drawer for years, suddenly becomes the most important document in the room.
In theory, a buy-sell agreement answers the obvious questions: who gets the deceased owner’s shares, how much they’re worth, and who pays for them. In practice, it’s rarely that clean.
You discover the agreement hasn’t been updated in a decade. The valuation formula references a balance sheet that no longer reflects reality. Life insurance that was meant to fund the buyout is held in the wrong entity, or worse, has lapsed. The deceased owner’s will says one thing. The shareholders’ agreement says another. And the constitution says something else entirely.
Now you have a dispute. Not because anyone set out to be difficult, but because documents written years ago, in different circumstances, are being tested by a death no one expected to happen yet.
This article walks through how buy-sell agreement disputes arise after a shareholder’s death, the flashpoints that drive conflict between surviving owners and the estate, and the practical steps both sides can take to manage the situation before it escalates into costly, destructive litigation.
Key Takeaways
- Disputes arise when buy-sell agreements, shareholder agreements, wills, and trust deeds conflict, leaving both sides uncertain about who controls the shares and what price applies.
- Outdated or vague valuation clauses trigger disagreements when the estate believes the buyout price undervalues the shares, and survivors insist on enforcing the agreed formula.
- Life insurance funding failures create immediate cash flow problems, especially when policies have lapsed, been redirected, or are held in structures that don’t align with the buyout obligation.
- Executors and beneficiaries have duties to protect estate value and must carefully assess whether the buy-sell terms are genuinely fair before agreeing to transfer shares.
- Surviving shareholders need control and continuity but must avoid overreaching or acting oppressively toward the estate during the transition.
- Early intervention through document review, independent valuation, and structured negotiation prevents disputes from hardening into litigation that damages the business and destroys relationships.
What a Buy-Sell Agreement Is Meant to Do When an Owner Dies
A buy-sell agreement is a contract between business owners that defines what happens to their shares or ownership interests when a triggering event occurs. Death is almost always one of those triggers.
The idea is simple: continuity and control. The surviving owners get the certainty of keeping the business among themselves. The deceased owner’s family or estate gets liquidity, an exit, and certainty that someone will buy them out at a defined price.
But agreements drafted years ago, in optimistic times, often make assumptions that don’t hold once someone actually dies.
The valuation method assumes the business will keep growing. The funding mechanism assumes life insurance will cover the cost. The agreement assumes everyone will cooperate. And critically, it assumes that the deceased owner’s shares, will, trust structures, and family circumstances will align neatly with the buyout process.
When those assumptions break down, the buy-sell agreement becomes the first battleground.
A buy-sell agreement is only as good as the circumstances in which it’s tested. If it hasn’t been reviewed, funded, or aligned with other documents, it won’t deliver the clean exit it promised.
How disputes arise after a shareholder dies
Most buy-sell agreement disputes don’t start with bad faith. They start with uncertainty, surprise, and misalignment. Here’s what typically goes wrong.
Misaligned documents and conflicting instructions
The buy-sell agreement might say the surviving shareholders have an option to purchase the deceased owner’s shares at a formula price. But the shareholders’ agreement includes pre-emption rights that were drafted separately and operate differently. The company constitution is silent on death but gives directors broad powers to refuse share transfers. And the deceased owner’s will leaves “my shares in XYZ Pty Ltd” to three beneficiaries, none of whom understand the business or knew they were about to become co-owners.
Now everyone is looking at different documents, reading different clauses, and coming to different conclusions about who has the right to buy, who has the obligation to sell, and what price applies.
If you’re an executor trying to administer the estate, your first question is simple: which document controls? If you’re a surviving director trying to secure the business, your first question is: who am I negotiating with, and what power do they actually have?
Before agreeing to anything, pull every document that touches ownership: the buy-sell agreement, shareholders’ agreement, company constitution, trust deed (if shares are held in trust), and the deceased owner’s will. Map out what each one says about death, transfers, and valuation.
Outdated or vague valuation clauses
Many buy-sell agreements include a valuation mechanism that was reasonable when drafted but hasn’t kept pace with the business. Common examples:
- “The shares will be valued at the price last agreed in writing by the parties.” That price was set eight years ago when revenue was half what it is today.
- “Fair market value as determined by the company’s accountant.” But the company’s accountant has been the same firm for twenty years, has close ties to the surviving directors, and the estate has zero confidence in their independence.
- “Net asset value per the most recent financial statements.” But the business holds significant goodwill, intangible assets, and customer relationships that aren’t captured on the balance sheet.
The estate looks at the formula and sees a number that feels wrong. The surviving owners look at the same clause and say, “This is what we all agreed to.”
Can the estate challenge a formula that’s technically enforceable but produces a result that undervalues the shares? That depends on the wording of the agreement, the circumstances in which it was signed, and whether the deceased owner had independent advice at the time.
What’s certain is this: disputes over valuation are the single most common trigger for buy-sell litigation after a death.
If the estate believes the valuation clause produces an unfair result, they should obtain an independent valuation before agreeing to any transfer. The agreement’s formula is a starting point, not always the end of the conversation.
Life insurance funding that isn’t there
Buy-sell agreements are often paired with life insurance policies meant to fund the buyout. The logic is elegant: the deceased owner’s death triggers both the buyout obligation and the insurance payout, so the survivors have cash to complete the purchase without draining the business.
In practice, insurance funding goes wrong in predictable ways:
- The policy was allowed to lapse years ago because premiums increased or cash flow tightened.
- The policy is owned by the company rather than the individual shareholders, so the proceeds land on the company’s balance sheet and create tax and distribution complications.
- The beneficiary designations were never updated after a restructure, and the money goes to the wrong entity or the wrong person.
- The insured amount was set when the business was smaller, and it no longer covers the buyout price.
- One shareholder was uninsurable or declined cover, creating an asymmetry where some deaths trigger funding and others don’t.
When the insurance isn’t there or doesn’t work as intended, the surviving shareholders face a brutal choice: find cash the business doesn’t have, negotiate staged payments the estate may not accept, or default on the buy-sell obligation and risk a claim for breach.
The estate, meanwhile, is left wondering whether they should hold the shares and wait for payment, or push for immediate action and risk destabilising the business.
In the first week after a shareholder’s death, surviving directors should confirm the status of any life insurance policies: are they current, who owns them, who is the beneficiary, and how much will they pay out? If the funding isn’t there, say so early and start working on alternatives.
Control surprises and governance uncertainty
Buy-sell agreements usually assume shares will transfer smoothly from the deceased owner to the survivors. But until that transfer happens, someone owns those shares. And ownership means voting rights, dividend entitlements, and the ability to influence the business.
If the deceased owner held shares personally, those shares typically vest in the executor. If the shares were held in a family trust, control passes according to the trust deed’s succession provisions. Either way, there’s often a period where the “new owner” has legal rights but zero knowledge of the business, creating friction with the surviving directors who are trying to keep things running.
Disputes arise when:
- The executor or beneficiaries believe they should have a say in major decisions until the buyout completes.
- Surviving directors take unilateral action, freeze out the estate’s representatives, or refuse to provide information.
- The agreement is silent on interim governance, so everyone assumes different things about who has authority.
Control uncertainty makes everyone nervous. And nervous people make bad decisions.
If you’re a surviving director, recognise that the estate’s representatives have legitimate governance rights until the buyout completes. Treat them transparently. If you’re an executor, understand the difference between protecting value and micromanaging a business you don’t run.
When the agreement, the constitution, and the estate plan don’t match
Here’s a scenario we see repeatedly.
The buy-sell agreement says the surviving shareholders have a right to purchase the deceased owner’s shares within 90 days at a price determined by the company’s accountant. The shareholders’ agreement includes a drag-along clause that allows a majority to force all shareholders to sell if an offer is received. The company constitution includes pre-emption rights requiring any proposed transfer to be offered first to existing shareholders. The deceased owner’s will leaves “my shares” to a discretionary trust for the benefit of their children.
Which document wins?
The answer depends on the hierarchy of documents, the timing of their execution, and whether any of them explicitly override the others. If the buy-sell agreement was signed last and says “this agreement prevails over any inconsistent provision in the constitution or prior agreements”, that’s a strong indicator. If the documents are silent on priority, you’re into a contractual interpretation fight.
And while the lawyers are figuring that out, the business is stuck.
For executors and beneficiaries, the risk is accidentally agreeing to something that contradicts the deceased owner’s intentions or breaches duties owed to the estate. For surviving owners, the risk is acting on one document while another imposes different obligations, exposing them to claims for breach or oppression.
If you’re dealing with multiple documents that touch ownership and succession, get advice on how they interact before anyone takes an irreversible step. A few hours of legal review now can prevent months of contested litigation later.
Valuation and funding disputes: why “agreed price” often isn’t agreed anymore
Buy-sell agreements typically specify a valuation method: a formula, a process, or a fixed price. The intention is to avoid post-death arguments about value. But in practice, valuation clauses are one of the biggest sources of dispute.
The problem with formula-based valuations
Formula valuations (net asset value, earnings multiples, discounted cash flow) are only as reliable as the assumptions they’re built on. A formula that worked when the business was stable and predictable may produce absurd results when the business has scaled, pivoted, or hit a rough patch.
The estate sees a thriving business and a formula that captures none of that value. The surviving owners see a clause everyone signed and expect it to be enforced. Both sides feel they’re being reasonable.
Can a formula valuation be challenged? Sometimes. If the formula produces a result that’s manifestly unreasonable, or if circumstances have changed so dramatically that enforcing the clause would be unconscionable, a court may be willing to intervene. But that’s a hard argument to run, and it’s expensive.
The better path is to negotiate early. If the estate genuinely believes the formula undervalues the shares, commission an independent valuation and present it alongside a proposal: “Here’s what we think fair value looks like. Here’s the gap. Let’s find a middle ground.”
Valuation disputes are almost always about information asymmetry and trust. If the surviving owners share financials, trading performance, and realistic projections, and if the estate engages an adviser who understands the business, many disputes resolve without litigation.
When life insurance funding falls short
Life insurance is supposed to remove funding risk. But when the payout is less than the buyout price, or when there’s no insurance at all, the business faces a liquidity problem.
Surviving shareholders may propose staged payments. The estate may push back, concerned that extended payment terms leave them exposed if the business deteriorates. Both sides have legitimate concerns.
Structured payment arrangements can work if:
- The terms are documented clearly, with security (personal guarantees, charges over assets) if the amounts are material.
- There’s transparency around business performance and cash flow, so the estate can see whether payments are realistic.
- Independent advisers (accountants, tax advisers, valuers) are involved to ensure the arrangement is commercially reasonable.
What doesn’t work is silence, delay, or unilateral terms presented as take-it-or-leave-it. That guarantees a dispute.
If the business can’t fund the buyout in full, propose a payment plan early, with supporting financials and security. If you’re the estate, don’t reject staged payments out of hand, but insist on terms that protect your interests if cash flow falters.
The estate’s perspective: executors, beneficiaries, and their duties
If you’re an executor or beneficiary who has just inherited shares in a closely held business, you’re in a tricky position.
You probably didn’t expect to become a shareholder. You may not understand the business. You’re being presented with a buy-sell agreement and told to sign a transfer at a price you’ve never seen analysed. And you have duties to the estate and beneficiaries that require you to act prudently and protect value.
Executor duties and the pressure to agree
Executors have a duty to realise estate assets and distribute them in accordance with the will. That duty includes not giving away value or agreeing to transactions on unfair terms.
If the buy-sell agreement specifies a price and process, the executor is generally expected to comply, provided the agreement is valid and enforceable. But if the price seems low, the process seems one-sided, or the surviving owners are pressuring you to move faster than is prudent, you’re entitled to slow down and get advice.
Ask for:
- A copy of the buy-sell agreement, shareholders’ agreement, constitution, and any related documents.
- Recent financial statements, management accounts, and any valuations that have been prepared.
- Confirmation of life insurance arrangements and whether proceeds will be available to fund the buyout.
- An explanation of the valuation method and how the proposed price was calculated.
If the surviving owners are evasive, refuse to provide information, or insist on immediate action without explanation, that’s a warning sign.
Executors should treat the buyout like any other significant estate transaction: with care, documentation, and advice. Signing a transfer because you’re told “that’s what the agreement says” is not sufficient if you haven’t verified the terms or considered whether they’re fair.
When beneficiaries want to hold the shares
Sometimes beneficiaries don’t want to sell. They believe the business has value, they want ongoing income, or they’re emotionally attached to the deceased owner’s legacy.
But if the buy-sell agreement gives the surviving owners a binding right to purchase, the estate may have no choice. The agreement typically overrides the beneficiaries’ preferences.
That said, if the buyout price is genuinely unfair, or if the surviving owners are acting in breach of the agreement or oppressively, the estate may have grounds to resist or seek alternative remedies, including an application for relief under the oppression provisions of the Corporations Act.
This is not a decision to make lightly. Oppression claims are serious, expensive, and relationship-destroying. But they exist precisely for situations where majority shareholders use their power unfairly against a minority interest, including an estate that’s being forced out on unreasonable terms.
If you’re a beneficiary who wants to retain shares, check whether the buy-sell agreement gives you that option. If it doesn’t, focus on ensuring the price is fair rather than fighting to stay in the business.
The surviving owners’ perspective: keeping the business stable without overreaching
If you’re a surviving shareholder or director, the death of a business partner is both a business crisis and a personal loss.
You need to maintain client relationships, manage staff, keep operations running, and deal with suppliers and lenders who are suddenly nervous about the business’s future. The last thing you need is a protracted fight with the deceased owner’s family over share transfers.
But you also need to be careful. If you act too quickly, shut out the estate, or take advantage of your control to impose unfair terms, you risk claims for breach of duty, breach of the buy-sell agreement, or oppression.
Control and continuity are legitimate goals
You have every right to want certainty and control. The business was built by you and your former partner, and it makes sense that you want to keep it that way.
But the estate’s representatives also have rights. Until the buyout completes, they own shares and are entitled to be treated as shareholders. That means:
- Access to financial information, board papers, and company records.
- Notice of and the right to attend general meetings.
- Payment of dividends (if the company is declaring them).
- Consultation on major decisions that affect share value.
If you freeze them out, refuse to provide information, or make major decisions unilaterally, you give them grounds to claim oppression or breach of directors’ duties.
Treat the estate’s representatives transparently and respectfully, even if they don’t understand the business. Share information proactively, answer questions promptly, and involve them in governance decisions until the buyout completes. It costs you nothing and prevents claims later.
Avoid oppressive conduct during the buyout process
Oppression, in the context of shareholder disputes, means conduct that is unfairly prejudicial or unfairly discriminatory against a shareholder. After a death, common examples include:
- Refusing to provide financials or explain the valuation.
- Stripping value out of the business (excessive salaries, related party transactions, asset sales) before the buyout completes.
- Forcing a sale at a price the estate hasn’t agreed to without following the process in the buy-sell agreement.
- Diluting the deceased owner’s shareholding or restructuring the business to reduce the value of their shares.
If the estate can show that your conduct as a director or majority shareholder has been oppressive, a court can make wide-ranging orders, including forcing you to buy the shares at a fair value determined by the court, rather than the price in the agreement.
That’s a risk you don’t want to take.
You can be firm and commercial without being oppressive. Enforce the buy-sell agreement, but do it transparently and in accordance with the process it specifies. Don’t take shortcuts that look like you’re taking advantage.
What to do early: practical steps to contain the dispute
Most buy-sell agreement disputes can be contained if both sides act early, transparently, and with advice.
Here’s what to do in the first weeks and months after a shareholder’s death.
Week one: secure the documents and confirm the position
Surviving directors should:
- Locate the buy-sell agreement, shareholders’ agreement, constitution, trust deeds, and any insurance policies.
- Confirm who now holds the deceased owner’s shares (the executor, a trust, or beneficiaries).
- Notify the company’s accountant, lawyer, and insurer of the death.
- Check the status of life insurance and when proceeds will be payable.
Executors and beneficiaries should:
- Request copies of all documents that govern ownership and succession.
- Confirm the deceased owner’s exact shareholding and any other interests in the business.
- Obtain recent financial statements and understand the business’s financial position.
- Notify the deceased owner’s lawyer and accountant.
Don’t wait for someone else to take the lead. If you’re a surviving director, be proactive in communicating with the estate. If you’re an executor, be proactive in requesting information. Early transparency prevents suspicion.
Weeks two to four: establish interim governance and agree a process
Buy-sell agreements often specify a timeframe for the buyout (30 days, 60 days, 90 days). Use that window to agree on a process, not to dig in on positions.
Key steps:
- Agree on who will represent the estate in negotiations (the executor, a family member, or an external adviser).
- Agree on a timeline for valuation, funding, and completion.
- If the valuation method in the agreement is unclear or contested, agree to obtain an independent valuation from a mutually acceptable expert.
- If funding is an issue, discuss payment terms and what security the estate would require.
- Establish interim governance arrangements: will the estate’s representative attend board meetings? Will they have access to management accounts? What decisions require their consent?
This isn’t about agreeing the final terms. It’s about agreeing how you’ll work through the issues without escalating into litigation.
Disputes escalate when one side feels shut out or blindsided. Regular communication, even when the news isn’t good, prevents that.
Months two to three: valuation, funding, and negotiation
If the buy-sell agreement specifies a clear valuation method and funding source, and both sides accept the result, the buyout can proceed quickly.
If not, this is where disputes either resolve or harden.
Options for resolving valuation disagreements:
- Commission an independent valuation from a chartered accountant or business valuer with experience in the industry.
- Agree to use the average of two independent valuations (one selected by each side).
- Engage a mediator to facilitate discussions around value and payment terms.
Options for resolving funding problems:
- Staged payments with interest and security.
- Using life insurance proceeds (if available) as a deposit, with the balance paid over time.
- Third-party funding (business loans, director loans, external investors).
- Restructuring the business to release cash (asset sales, dividend distributions, refinancing).
What doesn’t work is unilateral action. If the surviving owners set a price and demand the estate accept it, or if the estate refuses to engage and threatens litigation, you’re headed for a destructive fight.
If negotiations stall, suggest early mediation. Mediation is confidential, non-binding, and often resolves disputes that would otherwise take years in court. Most buy-sell agreements include a dispute resolution clause requiring mediation before litigation.
If the dispute can’t be resolved: know the litigation pathways
If early negotiation fails, the dispute may escalate into litigation. Common claims include:
- Breach of the buy-sell agreement (failure to complete the buyout, failure to pay the agreed price).
- Breach of directors’ duties (acting in self-interest, failing to act in the company’s best interests).
- Oppression under section 232 of the Corporations Act (unfairly prejudicial conduct by majority shareholders or directors).
- Claims for declarations about the proper interpretation of the buy-sell agreement or related documents.
- Claims for equitable remedies (specific performance, injunctions, orders for the provision of information).
Litigation should be a last resort, not a first move. But if one side is acting in bad faith, refusing to comply with clear obligations, or engaging in oppressive conduct, it may be necessary.
If you’re considering litigation, move quickly. Delays weaken your position and allow the other side to consolidate control or strip value.
Litigation over buy-sell disputes is expensive and slow, but it’s sometimes the only way to protect your rights. If you’re going to litigate, do it with a clear strategy, focused on the issues that will actually decide the case.
Looking ahead: how to review and adjust buy-sell arrangements before they’re tested
The disputes outlined in this article are preventable. Not all of them, but most.
If you’re a business owner with a buy-sell agreement that hasn’t been reviewed in years, here’s what you should do now, before a death or other triggering event tests it.
Update your documents regularly
Buy-sell agreements should be reviewed:
- Whenever the business structure changes (new shareholders, restructures, changes in ownership).
- Whenever the value of the business changes materially (expansion, contraction, new revenue streams, major contracts).
- Whenever shareholders’ personal circumstances change (marriage, divorce, estate planning, changes in wealth or risk profile).
- At least every three to five years as a matter of course.
Update the valuation method to reflect how the business is actually valued today, not how it was valued when the agreement was signed.
Align your documents
Make sure your buy-sell agreement, shareholders’ agreement, company constitution, trust deeds, wills, and estate plans all say consistent things about what happens on death.
If you hold shares in trust, ensure the trust deed’s succession provisions align with the buy-sell agreement. If your will leaves shares to specific beneficiaries, make sure that’s consistent with any obligation to sell them to the surviving owners.
Misalignment is the number one cause of post-death disputes.
Fund the buyout properly
Review life insurance arrangements annually. Confirm:
- Policies are current and premiums are being paid.
- The insured amount reflects the current buyout price.
- The policy owner and beneficiary designations align with the buy-sell agreement.
- Tax and structuring advice has been obtained to ensure insurance proceeds can be used as intended.
If insurance isn’t available or isn’t sufficient, document alternative funding arrangements in the buy-sell agreement.
Build in dispute resolution mechanisms
Include clear dispute resolution clauses in your buy-sell agreement:
- Mediation before litigation.
- Expert determination for valuation disputes (binding or non-binding).
- Clear timelines and processes for each step.
Make it easy to resolve disagreements without going to court.
Treat your buy-sell agreement like a living document, not something you sign once and file away. The businesses that avoid disputes are the ones that review, update, and align their agreements regularly.
Conclusion
When a shareholder dies, the buy-sell agreement is supposed to provide certainty. But certainty only comes from clarity: clear terms, clear funding, clear alignment between documents, and clear communication between the parties.
Disputes arise when that clarity is missing. When valuation clauses are outdated. When insurance funding isn’t there. When the agreement, the constitution, and the will all say different things. When executors and survivors don’t trust each other and don’t know what the other side is entitled to do.
The disputes that cause the most damage are the ones that could have been prevented with early action: reviewing documents, commissioning valuations, agreeing a process, and seeking advice before positions harden.
If you’re a surviving business owner, act transparently and comply with the agreement’s process. If you’re an executor or beneficiary, protect the estate’s interests but engage constructively. And if you’re a business owner reading this while everyone is still alive, review your buy-sell agreement now, before it’s tested by a death.
Litigation over buy-sell agreements is avoidable. But avoiding it requires clarity, preparation, and the discipline to act early when a dispute first surfaces.
Disclaimer: This article provides general information only and does not constitute legal advice. Buy-sell agreement disputes involve complex legal, tax, and commercial issues that depend on the specific terms of your agreements and the circumstances of your business. If you are dealing with a dispute after a shareholder’s death, or if you need to review or update your buy-sell arrangements, you should obtain legal advice tailored to your situation.
